SPDR S&P Biotech ETF (NYSEARCA:XBI) Reaches New 1-Year High – Here’s Why

Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) reached a new 52-week high during trading on Thursday . The stock traded as high as $103.89 and last traded at $103.27, with a volume of 1307776 shares changing hands. The stock had previously closed at $102.44.

SPDR S&P Biotech ETF Stock Performance

The company has a market capitalization of $7.94 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm has a 50-day simple moving average of $98.96 and a two-hundred day simple moving average of $95.52.

Institutional Trading of SPDR S&P Biotech ETF

Large investors have recently made changes to their positions in the stock. Fifth Third Bancorp grew its holdings in SPDR S&P Biotech ETF by 3.4% in the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock worth $10,968,000 after buying an additional 3,922 shares in the last quarter. Avantax Advisory Services Inc. increased its position in SPDR S&P Biotech ETF by 17.2% during the first quarter. Avantax Advisory Services Inc. now owns 9,619 shares of the exchange traded fund’s stock worth $913,000 after buying an additional 1,415 shares during the last quarter. PFG Investments LLC boosted its position in SPDR S&P Biotech ETF by 9.2% during the second quarter. PFG Investments LLC now owns 24,844 shares of the exchange traded fund’s stock worth $2,303,000 after purchasing an additional 2,097 shares during the period. IFG Advisory LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $241,000. Finally, Atria Wealth Solutions Inc. boosted its stake in SPDR S&P Biotech ETF by 56.1% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock valued at $1,539,000 after purchasing an additional 5,962 shares during the period.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.